CARsgen Therapeutics Holdings Ltd.'s market cap is currently HK$7.28B. The company's EPS TTM is HK$-1.328; its P/E ratio is ―; CARsgen Therapeutics Holdings Ltd. is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is HK$-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 25.81M	¥ 0.00	¥ 0.00
Gross Profit	¥ 0.00	¥ 0.00	¥ 25.81M	¥ 0.00	¥ 0.00
Operating Income	¥ -767.65M	¥ -881.30M	¥ -585.99M	¥ -327.05M	¥ -227.40M
EBITDA	¥ -717.64M	¥ -793.90M	¥ -517.89M	¥ -286.17M	¥ -206.40M
Net Income	¥ -747.79M	¥ -892.25M	¥ -4.74B	¥ -1.80B	¥ -304.30M
Balance Sheet
Cash & Short-Term Investments	¥ 1.85B	¥ 2.27B	¥ 3.01B	¥ 1.04B	¥ 96.48M
Total Assets	¥ 2.26B	¥ 2.76B	¥ 3.51B	¥ 1.25B	¥ 325.81M
Total Debt	¥ 85.22M	¥ 119.44M	¥ 338.05M	¥ 100.26M	¥ 84.33M
Net Debt	¥ -1.76B	¥ -2.15B	¥ -353.24M	¥ -942.71M	¥ -12.15M
Total Liabilities	¥ 455.51M	¥ 289.64M	¥ 508.98M	¥ 2.93B	¥ 1.06B
Stockholders' Equity	¥ 1.80B	¥ 2.47B	¥ 3.00B	¥ -1.68B	¥ -732.60M
Cash Flow
Free Cash Flow	¥ -464.48M	¥ -781.66M	¥ -690.77M	¥ -313.88M	¥ -282.46M
Operating Cash Flow	¥ -454.94M	¥ -643.05M	¥ -512.32M	¥ -295.15M	¥ -179.00M
Investing Cash Flow	¥ 39.25M	¥ 2.39B	¥ -2.47B	¥ -6.90M	¥ 82.98M
Financing Cash Flow	¥ -22.14M	¥ -236.51M	¥ 2.67B	¥ 1.30B	¥ 27.53M

Currency in CNY

CARsgen Therapeutics Holdings Ltd. Earnings and Revenue History

Income Statement >

CARsgen Therapeutics Holdings Ltd. Debt to Assets

Balance Sheet >

CARsgen Therapeutics Holdings Ltd. Cash Flow

Cash Flow >

CARsgen Therapeutics Holdings Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing